OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
08264059

Tongyang Life Insurance Co Ltd

Life & Health InsuranceVerified

Tongyang Life Insurance Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.81, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with cash and equivalents amounting to 250.37 billion KRW, while its long-term debt stands at 1.25 trillion KRW. The company's return on equity is 8.04%, which is a strong indicator of its ability to generate returns for shareholders. In terms of profitability, Tongyang Life Insurance Co Ltd reported a net income of 124.49 billion KRW and an operating income of 138.83 billion KRW. The return on assets of 0.35% suggests that the company is not generating significant returns relative to its total assets, which is below the typical performance for the insurance industry. This may indicate inefficiencies in asset utilization or a challenging operating environment. The company's geographic and segment exposure is not explicitly detailed in the available data, but as a life and health insurance provider in South Korea, it is likely concentrated in domestic markets. The absence of detailed segment data limits the ability to assess diversification or concentration risks in specific product lines or regions. Tongyang Life Insurance Co Ltd's growth trajectory is not clearly defined in the provided data, but the company's operating cash flow of 2.65 trillion KRW and free cash flow of 135.41 billion KRW suggest a strong cash-generating capability. The capital expenditure of -15.34 billion KRW indicates a reduction in capital spending, which could be a strategic decision to preserve cash or a reflection of asset disposals. The risk assessment for Tongyang Life Insurance Co Ltd highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose challenges in maintaining liquidity under stress scenarios. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value. Recent events and filings do not provide specific details on new initiatives or strategic changes for Tongyang Life Insurance Co Ltd. Analyst estimates suggest a mean price target of 7,350.00 KRW, with a median price target of 7,350.00 KRW, indicating a relatively neutral outlook from the market. The mean recommendation of 2.50 suggests a mixed sentiment, with one buy and one hold recommendation, and no strong buy or sell ratings.

30-day price · 082640(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyTongyang Life Insurance Co Ltd
Ticker082640.KS
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Tongyang Life Insurance Co Ltd provides life and health insurance products and services in South Korea.

Classification. Tongyang Life Insurance Co Ltd is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92.

Tongyang Life Insurance Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.81, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with cash and equivalents amounting to 250.37 billion KRW, while its long-term debt stands at 1.25 trillion KRW. The company's return on equity is 8.04%, which is a strong indicator of its ability to generate returns for shareholders. In terms of profitability, Tongyang Life Insurance Co Ltd reported a net income of 124.49 billion KRW and an operating income of 138.83 billion KRW. The return on assets of 0.35% suggests that the company is not generating significant returns relative to its total assets, which is below the typical performance for the insurance industry. This may indicate inefficiencies in asset utilization or a challenging operating environment. The company's geographic and segment exposure is not explicitly detailed in the available data, but as a life and health insurance provider in South Korea, it is likely concentrated in domestic markets. The absence of detailed segment data limits the ability to assess diversification or concentration risks in specific product lines or regions. Tongyang Life Insurance Co Ltd's growth trajectory is not clearly defined in the provided data, but the company's operating cash flow of 2.65 trillion KRW and free cash flow of 135.41 billion KRW suggest a strong cash-generating capability. The capital expenditure of -15.34 billion KRW indicates a reduction in capital spending, which could be a strategic decision to preserve cash or a reflection of asset disposals. The risk assessment for Tongyang Life Insurance Co Ltd highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose challenges in maintaining liquidity under stress scenarios. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value. Recent events and filings do not provide specific details on new initiatives or strategic changes for Tongyang Life Insurance Co Ltd. Analyst estimates suggest a mean price target of 7,350.00 KRW, with a median price target of 7,350.00 KRW, indicating a relatively neutral outlook from the market. The mean recommendation of 2.50 suggests a mixed sentiment, with one buy and one hold recommendation, and no strong buy or sell ratings.
Key takeaways
  • Tongyang Life Insurance Co Ltd has a strong operating income and net income, indicating solid profitability.
  • The company's return on equity is 8.04%, which is a positive sign for shareholders.
  • The debt-to-equity ratio of 0.81 suggests a moderate level of leverage.
  • The company's liquidity position is characterized as medium, with a negative net cash position after subtracting total debt.
  • Analysts have a mixed outlook, with a mean recommendation of 2.50 and a mean price target of 7,350.00 KRW.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue
Gross profit
Operating income$138.83B
Net income$124.49B
R&D
SG&A
D&A
SBC
Operating cash flow$2.65T
CapEx-$15.34B
Free cash flow$135.41B
Total assets$35.35T
Total liabilities$33.80T
Total equity$1.55T
Cash & equivalents$250.37B
Long-term debt$1.25T
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.55T
Net cash-$999.93B
Current ratio
Debt/Equity0.8
ROA0.4%
ROE8.0%
Cash conversion21.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
Metric082640Activity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity81.0%48.5% medp25 43.7% · p75 53.3%top quartile
Observations
IR observations
Mean price target7,350.00 KRW
Median price target7,350.00 KRW
High price target8,000.00 KRW
Low price target6,700.00 KRW
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1,443.00 KRW
Last actual EPS798.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 10:37 UTCJob: aaed6af2